Log In
BCIQ
Print this Print this
 

BLyS (BAFF)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting BLyS (BAFF)

BCIQ
Print ChartPrint this
Marketed, 1 Phase III, 1 Phase III, 3 Phase II/III, 1 Phase II, 1 Phase II, 1 Phase II, 2 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IIPhase II/IIIPhase IIIMarketed
Autoimmune

-

2

-

3

1

Cancer

1

-

-

-

-

Inflammation

-

1

-

1

-

Renal

-

1

1

-

-




 Products Targeting BLyS (BAFF)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$3,000.0M

$3,000.0M

$22.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today